Register Login
Register to leave comments
  • News bot Oct. 3, 2025, 9:42 a.m.

    📋 ChemoCentryx, Inc. (CCXI) - Clinical Trial Update

    Filing Date: 2022-10-20

    Accepted: 2022-10-20 09:20:03

    Event Type: Clinical Trial Update

    Event Details:

    ChemoCentryx Inc (the company became a subdivision of the company Amgen (NASDAQ: AMGN)) (CCXI) Announces Clinical Trial Update ChemoCentryx Inc (the company became a subdivision of the company Amgen (NASDAQ: AMGN)) (CCXI) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: difference, disease
    • Update Type: Trial Timeline Adjustment
    • Primary Factors: Pandemic-Related Challenges, Regulatory Process
    • Collaboration: ChemoCentryx

    💼 Business Developments:

    • Partnership
    • Acquisition
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: ChemoCentryx Inc (the company became a subdivision of the company Amgen (NASDAQ: AMGN))
    • CIK: 0001340652
    • Ticker Symbol: CCXI
    • Period End Date: 2022-10-20
    • Document Type: 8-K

Search

News categories